Mukka Proteins Limited / Fundamentals
Income statement
- Net revenue
€98.56M - Cost of goods sold
€75.93M - Gross profit
€21.43M - SG&A expenses
€2.48M - R&D expenses
€0.00 - EBITDA
€9.43M - D&A
€1.29M - EBIT
€13.54M - Interest expenses
€1.65M - EBT
€5.84M - Tax expenses
€1.27M - Net income
€4.52M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€4.52M - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€4.14M - Cash and short-term investments
€4.14M - Total receivables
€19.57M - Inventory
€55.26M - Other current assets
€11.69M - Total current assets
€90.66M - Property, plant & equipment
€9.25M - Goodwill
€661.07K - Intangible assets
€6.76K - Long-term investments
€3.59M - Other non-current assets
€1.24M - Total non-current assets
€14.75M - Total assets
€105.41M - Accounts payable
€13.89M - Short-term debt
€44.01M - Other current liabilities
€1.94M - Total current liabilities
€59.84M - Long-term debt
€345.23K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€516.42K - Total non-current liabilities
€861.64K - Total liabilities
€60.70M - Common stock
€2.94M - Retained earnings
€0.00 - Other equity
€40.22M - Total equity
€44.71M - Total liabilities and shareholders' equity
€105.41M
Company information
- Market capitalization
€133.60M - Employees
414 - Enterprise Value
€13.53B
Company ratios
- Gross margin
-
21.7% - EBITDA margin
-
9.6% - EBIT margin
-
13.7% - EBT margin
-
5.9% - Net margin
-
4.6% - ROE
-
10.1% - ROA
-
4.3% - Asset turnover
-
93.5% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
90.4% - Net sales per employee
-
€238.08K - Net income per employee
-
€10.92K